Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury

Circulation. 2008 Mar 18;117(11):1405-13. doi: 10.1161/CIRCULATIONAHA.107.745539. Epub 2008 Mar 3.

Abstract

Background: Opening of cardiac ATP-sensitive potassium channels (K(ATP) channels) is a well-characterized protective mechanism against ischemia and reperfusion injury. Evidence exists for an involvement of both sarcolemmal and mitochondrial K(ATP) channels in such protection. Classically, cardiac sarcolemmal K(ATP) channels are thought to be composed of Kir6.2 (inward-rectifier potassium channel 6.2) and SUR2A (sulfonylurea receptor type 2A) subunits; however, the evidence is strong that SUR1 (sulfonylurea receptor type 1) subunits are also expressed in the heart and that they may have a functional role. The aim of this study, therefore, was to examine the role of SUR1 in myocardial infarction.

Methods and results: We subjected mice lacking SUR1 subunits to in vivo myocardial ischemia/reperfusion injury. Interestingly, the SUR1-null mice were markedly protected against the ischemic insult, displaying a reduced infarct size and preservation of left ventricular function, which suggests a role for this K(ATP) channel subunit in cardiovascular function during conditions of stress.

Conclusions: SUR1 subunits have a high sensitivity toward many sulfonylureas and certain K(ATP) channel-opening drugs. Their potential role during ischemic events should therefore be considered both in the interpretation of experimental data with pharmacological agents and in the clinical arena when the cardiovascular outcome of patients treated with antidiabetic sulfonylureas is being considered.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / biosynthesis
  • ATP-Binding Cassette Transporters / drug effects
  • ATP-Binding Cassette Transporters / genetics
  • ATP-Binding Cassette Transporters / physiology*
  • Animals
  • Diabetes Complications / physiopathology
  • Fibrosis
  • Hypoglycemic Agents / pharmacology
  • KATP Channels / chemistry
  • KATP Channels / drug effects
  • KATP Channels / physiology*
  • Mice
  • Mice, Knockout
  • Multidrug Resistance-Associated Proteins / deficiency
  • Multidrug Resistance-Associated Proteins / drug effects
  • Multidrug Resistance-Associated Proteins / genetics
  • Multidrug Resistance-Associated Proteins / physiology*
  • Myocardial Infarction / complications
  • Myocardial Infarction / genetics*
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology
  • Myocardial Reperfusion Injury / genetics*
  • Myocardial Reperfusion Injury / physiopathology
  • Myocarditis / etiology
  • Myocarditis / genetics
  • Myocarditis / prevention & control
  • Myocytes, Cardiac / physiology
  • Patch-Clamp Techniques
  • Potassium Channels / biosynthesis
  • Potassium Channels / genetics
  • Potassium Channels, Inwardly Rectifying / biosynthesis
  • Potassium Channels, Inwardly Rectifying / genetics
  • Receptors, Drug / biosynthesis
  • Receptors, Drug / genetics
  • Sulfonylurea Compounds / pharmacology
  • Sulfonylurea Receptors
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / genetics*
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Dysfunction, Left / prevention & control

Substances

  • ATP-Binding Cassette Transporters
  • Abcc8 protein, mouse
  • Abcc9 protein, mouse
  • Hypoglycemic Agents
  • KATP Channels
  • Kir6.2 channel
  • Multidrug Resistance-Associated Proteins
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Receptors, Drug
  • Sulfonylurea Compounds
  • Sulfonylurea Receptors
  • uK-ATP-1 potassium channel